Beth Salcedo
CE Credit
0.00
June 14, 2018
Beth Salcedo, MD

Psychotropic medications are some of the most widely prescribe

Presentation Type
CE/CME Credit
1.00
July 14, 2020
Patricia Zurita Ona, PsyD
This webinar delves into the nuts and bolts of how to conduct an ACT consistent exposure session, starting with a contextual-functional assessment of OCD symptoms, organizing a values-based exposure menu, increasing clients’ willingness to get out from their fear-based zone and move into values-based exposures, and troubleshooting when getting stuck in an exposure session (e.g. clients have a high degree of believability on thought – action – fusion, client’s continue to have hopes for obsessions to go away, clients’ exposures turn into rituals, etc). 
Presentation Type
CE Credit
0.00
July 2, 2020
Sierra Carter, PhD
This webinar provides an overview of the ways in which racial discrimination impacts the health and well-being of Black Americans, a marginalized population that disproportionately experiences racial health disparities influenced by race-related stress. This webinar also further elucidate the importance of examining racial discrimination in the conceptualization of trauma experiences and treatments.
Presentation Type
CE Credit
1.00
CE/CME Credit
1.00
July 21, 2020
Fugen Neziroglu, PhD, ABPP, ABBP

Body Dysmorphic Disorder (BDD) is classified under obsessive-compulsive spectrum disorders due to its many shared similarities with OCD, including preoccupations associated with engagement in safety behaviors. Patients with BDD have a perceived or imagined defect in their physical appearance, and

Presentation Type
CE Credit
0.00
June 11, 2020
Shiri Sadeh-Sharvit, PhD

The COVID-19 pandemic has dramatically changed the landscape of digital therapy, making telehealth a staple in the therapist toolkit.

Presentation Type
CE/CME Credit
1.00
June 8, 2020
Eli Lebowitz, PhD
Yaara Shimshoni, PhD
This webinar presents attendees with an overview of family accommodation and its associations with child anxiety and provide an introduction to the SPACE Program. Clinical trials in anxiety and OCD support the ability of SPACE to reduce family accommodation children's symptoms. Results of a recently completed funded randomized clinical trial of SPACE are presented and discussed.
Presentation Type
CE/CME Credit
1.00
May 28, 2020
Rajiv Radhakrishnan MBBS, MD
Kevin A. Sabet, PhD

As of February 2020, “medical marijuana” has been approved in 33 states, District of Columbia, Guam, Puerto Rico and US Virgin Islands in the US and Canada. Additionally 14 states and territories have approved recreational adult-use of marijuana.

Presentation Type
CE Credit
0.00
May 15, 2020
Dena DeFazio, Esq., M.S.W.

This webinar will provide the basic information that mental health providers should know regarding the changes to telemental health during the COVID-19 pandemic, including brief overviews of a variety of federal and New York State policies and guidance.

Presentation Type
CE Credit
0.00
May 8, 2020
Nathaniel Van Kirk, PhD

This presentation provides an overview of intensive/residential treatment (I/RT) programs for OCD and related disorders.

Presentation Type
Igor Galynker
CE/CME Credit
1.00
May 13, 2020
Igor Galynker, MD, PhD

According to the recent Center for Disease Control (CDC) report, more than half of suicide decedents between 2000 and 2016 were never diagnosed with a mental health condition, and only a quarter disclosed suicide intent prior to ending their lives.

Presentation Type

Advertisement